These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Cortico-limbic response to personally challenging emotional stimuli after complete recovery from depression. Hooley JM; Gruber SA; Parker HA; Guillaumot J; Rogowska J; Yurgelun-Todd DA Psychiatry Res; 2009 Feb; 171(2):106-19. PubMed ID: 19176279 [TBL] [Abstract][Full Text] [Related]
27. Severe and symptomatic hyponatremia following duloxetine treatment. Müssig K; Mörike K; Häring HU J Psychopharmacol; 2009 May; 23(3):338-9. PubMed ID: 18562431 [No Abstract] [Full Text] [Related]
28. A review on cognitive impairments in depressive and anxiety disorders with a focus on young adults. Castaneda AE; Tuulio-Henriksson A; Marttunen M; Suvisaari J; Lönnqvist J J Affect Disord; 2008 Feb; 106(1-2):1-27. PubMed ID: 17707915 [TBL] [Abstract][Full Text] [Related]
29. Neural basis of the emotional Stroop interference effect in major depression. Mitterschiffthaler MT; Williams SC; Walsh ND; Cleare AJ; Donaldson C; Scott J; Fu CH Psychol Med; 2008 Feb; 38(2):247-56. PubMed ID: 17825123 [TBL] [Abstract][Full Text] [Related]
30. Drugs for depression and bipolar disorder. Treat Guidel Med Lett; 2010 May; 8(93):35-42. PubMed ID: 20414177 [No Abstract] [Full Text] [Related]
31. On 'cognitive dysfunction' as a novel target for antidepressant treatment. Impey B; Baldwin DS Hum Psychopharmacol; 2013 Nov; 28(6):535-7. PubMed ID: 24519689 [No Abstract] [Full Text] [Related]
32. [Cognitive deficits in depression]. Kalska H; Kähkönen S Duodecim; 2004; 120(14):1738-44. PubMed ID: 15497307 [No Abstract] [Full Text] [Related]
33. White matter hyperintensity progression and late-life depression outcomes. Taylor WD; Steffens DC; MacFall JR; McQuoid DR; Payne ME; Provenzale JM; Krishnan KR Arch Gen Psychiatry; 2003 Nov; 60(11):1090-6. PubMed ID: 14609884 [TBL] [Abstract][Full Text] [Related]
34. Brain stimulation therapies for mood disorders: the continued necessity of electroconvulsive therapy. Nahas Z; Anderson BS J Am Psychiatr Nurses Assoc; 2011; 17(3):214-6. PubMed ID: 21653491 [No Abstract] [Full Text] [Related]
35. Neuropsychological impairment in major depression: its nature, origin and clinical significance. Porter RJ; Bourke C; Gallagher P Aust N Z J Psychiatry; 2007 Feb; 41(2):115-28. PubMed ID: 17464689 [TBL] [Abstract][Full Text] [Related]
36. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. Dougherty DD; Rauch SL Psychiatr Clin North Am; 2007 Mar; 30(1):91-103. PubMed ID: 17362806 [TBL] [Abstract][Full Text] [Related]
37. Major depressive disorder, antidepressants, and sexual dysfunction. Clayton AH; Montejo AL J Clin Psychiatry; 2006; 67 Suppl 6():33-7. PubMed ID: 16848675 [TBL] [Abstract][Full Text] [Related]
38. Neuropsychological prediction of recovery in late-onset major depression. Marcos T; Portella MJ; Navarro V; Gastó C; Rami L; Lázaro L; Salamero M Int J Geriatr Psychiatry; 2005 Aug; 20(8):790-5. PubMed ID: 16035125 [TBL] [Abstract][Full Text] [Related]
40. Do glutamatergic agents represent a new class of antidepressant drugs? Part 2. Sanacora G J Clin Psychiatry; 2009 Nov; 70(11):1604-5. PubMed ID: 20031105 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]